Charles River Labs CRADL

In operation since 1981, Genzyme Corporation is one of the leading biotechnology companies in the world. The company employs a staff of more than 12,000 people and manages over 85 locations in nearly 40 countries. It focuses on the areas of hematologic oncology, biosurgery, transplant, genetic diseases, and cardiometabolic and renal. Genzyme Corporation offers Fabrazyme, which is a solution for intravenous infusion. The company also provides Fabrazyme, Renagel, Renvela and Hectorol. It offers solutions for the medical and patient communities. In addition, Genzyme Corporation offers Synvisc, which is a viscosupplementation treatment for relieving knee pain associated with osteoarthritis. The company provides Sepra, which is a line of hyaluronic acid-based products.

Pegasystems, headquartered in Cambridge, Mass., provides software to automate business processes. Through its unified process and rules technology, it gives businesses and information technology departments the ability to use processes across the enterprise. Its products make customers' enterprise systems easy to use and change, by replacing policy manuals, system specifications and lines of manual coding, with dynamically responsive updates. The company s products are used by various businesses, including financial services, insurance and health care, and manufacturing and government markets. Its best-practice solution frameworks complement its standards-based Business Process Management technology suite. Pegasystems has regional offices in North America, Europe and the Pacific Rim.